GL1X · GenesisL1 explorer

MolNFT v1 · #188400 · protein

Structure of SARS-cov-2 3CL protease in complex with the cyclopropane based inhibitor 1C

7TQ2 · 3C-like proteinase: “Structure of SARS-cov-2 3CL protease in complex with the cyclopropane based inhibitor 1C”. X-ray diffraction, 1 ligand (ISG), 5 pockets (best druggability 0.77). MolNFT v1 #188400 on GenesisL1: 3D structure…

PDB
7TQ2
Type
protein
Length
596 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
ISG
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein29527% helix, 29% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30127% helix, 29% strandP0DTD1

Ligands and binding sites

  • ISG · N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-({[(1R,2R)-2-phenylcyclopropyl]methoxy}carbonyl)-L-leucinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18820.770.8075empty
21900.570.8036empty
32090.540.7822ISG
41910.520.7830ISG
5520.300.7618empty

Interfaces

1 interface between chains.

  • A–B · 1110 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7TQ2 · Structure of SARS-CoV-2 3CL protease in complex with the cyclopropane based inhibitor 1c · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.